SCHEMBL3015474

SCHEMBL3015474

CCOc1ccccc1CC(=O)CCl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.53
MAPT P10636 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TSHR P16473 1/20 0.50
ALDH1A1 P00352 3/20 0.49
GLA P06280 1/20 0.49
HCRTR1 O43613 2/20 0.47
GLS O94925 2/20 0.45
KDM4E B2RXH2 2/20 0.45
HTR7 P34969 1/20 0.45
GAA P10253 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
THRB P10828 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
ATM Q13315 1/20 0.44
PLEC Q15149 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14765242 0.86 L3MBTL1 (0.56) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL3005345 0.83 TAAR1 (0.54) MAPTNPSR1TSHRGAAMEN1
SCHEMBL2525348 0.83 L3MBTL1 (0.56) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL1628791 0.81 L3MBTL1 (0.62) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL4011789 0.81 L3MBTL1 (0.58) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL23478172 0.81 L3MBTL1 (0.70) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL6972541 0.81 L3MBTL1 (0.58) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL31274509 0.81 L3MBTL1 (0.70) L3MBTL1MAPTNPSR1TSHRALDH1A1
SCHEMBL29718904 0.81 L3MBTL1 (0.58) L3MBTL1MAPTNPSR1TSHRALDH1A1
Hydrochloric Acid SCHEMBL2525349 0.79 L3MBTL1 (0.61) L3MBTL1MAPTNPSR1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA L3MBTL1 1847/4885MAPT 18/4885NPSR1 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.